Statement of Organization, Functions, and Delegations of Authority, 5007-5008 [2023-01567]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 17 / Thursday, January 26, 2023 / Notices
focus group testing, with additional
variations informed by, among other
things, focus group results (see https://
www.reginfo.gov/public/do/PRAViewIC?
ref_nbr=202008-0910-021&icID=253321
for information about FDA’s front-ofpack focus groups, including graphic
FOP schemes tested). The study will be
a controlled, randomized experiment
that will use a 15-minute web-based
questionnaire to collect information
from 3,000 U.S. adult members of an
online consumer panel maintained by a
contractor. The sample will be balanced
to reflect the U.S. Census on gender,
education, age, and ethnicity/race. A
measure of nutrition literacy will also be
used to balance the sample to ensure a
variety of literacy levels for each
condition.
Conditions for the study will be: (1)
a set of draft FOP schemes, including
‘‘no-scheme’’ controls; (2) three types of
mock food products (i.e., a breakfast
cereal, a frozen meal, and a canned
soup); and (3) a ‘‘no-information’’
condition where no explanation of the
FOP scheme is provided. Each
participant will be randomly assigned to
a condition, which will include viewing
a label image and responding to various
measures of the label’s effectiveness.
Some assignments may include making
a choice between two label images.
Product perceptions (e.g., healthfulness
and contribution to a healthy diet), label
perceptions (e.g., believability,
trustworthiness, and effects
perceptions), and purchase/choice
questions will constitute the measures
of response in the experiment. The
5007
instrument will also collect information
from participants about their history of
purchasing or consuming similar
products, nutrition knowledge, dietary
interests, motivation regarding label use,
health status, and demographic
characteristics.
The studies are part of our continuing
effort to help enable consumers to make
informed dietary choices and construct
healthful diets. We intend to use the
results to inform our continued
exploration of an FOP labeling scheme.
We will not use the results to develop
population estimates.
Description of Respondents:
Respondents to this collection of
information include members of the
general public.
FDA estimates the burden of this
collection of information as follows:
TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1
Number of
respondents
Activity
Number of
responses per
respondent
Total annual
responses
Total hours
Experiment Pretest 1 ...................................................
Experiment Pretest 2 ...................................................
Experiment ...................................................................
180
25
3,000
1
1
1
180
25
3,000
0.25 (15 minutes) ..
0.25 (15 minutes) ..
0.25 (15 minutes) ..
45
6
750
Total ......................................................................
........................
........................
........................
................................
801
1 There
are no capital costs or operating and maintenance costs associated with this collection of information.
Dated: January 23, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
Operations, Food and Drug
Administration, 3 White Flint North,
11601 Landsdown Street, North
Bethesda, MD 20852, 240–402–3156.
SUPPLEMENTARY INFORMATION:
[FR Doc. 2023–01551 Filed 1–25–23; 8:45 am]
BILLING CODE 4164–01–P
I. Introduction
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions,
and Delegations of Authority
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA), Office of
Operations (OO), Office of Talent
Solutions (OTS) has modified its
structure, and the Office of FDA
Commissioned Corps (OFCC) was
established. These new organizational
structures were approved by the Deputy
Secretary of Health and Human Services
on September, 26, 2022, and effective on
November, 2, 2022.
FOR FURTHER INFORMATION CONTACT:
Tiffany Branch, Associate Director for
Management, Office of Enterprise
Management Services, Office of
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Average burden
per response
VerDate Sep<11>2014
17:17 Jan 25, 2023
Jkt 259001
Part D, Chapter D–B, (Food and Drug
Administration), the Statement of
Organization, Functions and
Delegations of Authority for the
Department of Health and Human
Services (35 FR 3685, February 25,
1970, 60 FR 56606, November 9, 1995,
64 FR 36361, July 6, 1999, 72 FR 50112,
August 30, 2007, 74 FR 41713, August
18, 2009, 76 FR 45270, July 28, 2011,
and 84 FR 22854, May 20, 2019) is
amended to reflect the reorganization of
the OO, OTS and establishment of OO,
OFCC.
This reorganization established the
OO, OFCC. In the OTS immediate office
realigned the Commissioned Corps Staff
(CCS) functions and resources to OO,
OFCC; established the Business
Operations Staff; retitled the Policy and
Accountability Staff to Policy, Programs,
and Accountability Staff; and abolished
the CCS.
In the Division of Talent Services, I
(DTS I) retitled the division to Division
of Talent Solutions I (DTS I); retitled the
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
CDER Branch 1 to Recruitment and
Staffing Branch 1; retitled the CDER
Branch 2 to Recruitment and Staffing
Branch 2; retitled the CDER Branch 3 to
Recruitment and Staffing Branch 3
(RSB3); established the Recruitment and
Staffing Branch 4; and established the
Special Pay and Hiring Branch.
In the Division of Talent Services II
(DTS II) retitled the division to Division
of Talent Solutions II (DTS II); retitled
the CFSAN and CVM Branch to
Recruitment and Staffing Branch 5;
retitled OC and NCTR Branch to
Recruitment and Staffing Branch 6;
retitled the OO Branch to Recruitment
and Staffing Branch 7; established the
Classification Branch 1; and established
the Classification Branch 2.
In the Division of Talent Services III
(DTS III) retitled the division to Division
of Talent Solutions III (DTS III);
realigned the CBER Branch functions
and resources to DTS I/RSB3; realigned
the CDRH Branch functions and
resources to DTS II and retitled as
Recruitment and Staffing Branch 8;
realigned the CTP Branch functions and
resources to DTS II and retitled as
Recruitment and Staffing Branch 9;
established the OTS/DTS III/Data
Quality Branch 2; established the Data
E:\FR\FM\26JAN1.SGM
26JAN1
5008
Federal Register / Vol. 88, No. 17 / Thursday, January 26, 2023 / Notices
Quality Branch 3; and established Data
Quality Branch 4.
In the Division of Talent Services IV
(DTS IV) realigned the ORA Branch 1
functions to DTS III and retitled as the
Recruitment and Staffing Branch 10;
realigned the ORA Branch 2 functions to
DTS III and retitled as the Recruitment
and Staffing Branch 11; and abolished
DTS IV.
In the Division of Talent Sourcing and
Staffing (DTSS) realigned the Corporate
Recruitment and Title 38 Branch
functions and resources to the OTS
Immediate Office Executive Resources
Staff and retitled as the Scientific
Programs and Executive Resources Staff;
realigned the Scientific Staffing and
Outreach Branch functions and
resources to the OTS Immediate Office
Scientific Talent Recruitment Staff and
retitled as the Science, Technology,
Engineering, and Mathematics Outreach
Staff; realigned the Customer Care and
Data Quality Branch functions and
resources to DTS III and retitled as the
Data Quality Branch 1; and abolished
DTSS.
Under Part D, FDA, OO, OTS has been
restructured as follows:
DCNJ. ORGANIZATION. The Office of
Talent Solutions is headed by the FDA
Chief Talent Officer and includes the
following organizational units:
lotter on DSK11XQN23PROD with NOTICES1
Business Operations Staff
Policy, Programs, and Accountability Staff
Scientific Programs and Executive Resources
Staff
Science, Technology, Engineering, and
Mathematics Outreach Staff
Division of Talent Solutions I
Recruitment and Staffing Branch 1
Recruitment and Staffing Branch 2
Recruitment and Staffing Branch 3
Recruitment and Staffing Branch 4
Special Hiring and Pay Branch
Division of Talent Solutions II
Recruitment and Staffing Branch 5
Recruitment and Staffing Branch 6
Recruitment and Staffing Branch 7
Recruitment and Staffing Branch 8
Recruitment and Staffing Branch 9
Classification Branch 1
Classification Branch 2
Division of Talent Solutions III
Recruitment and Staffing Branch 10
Recruitment and Staffing Branch 11
Delegated Examining Branch
Data Quality Branch 1
Data Quality Branch 2
Data Quality Branch 3
Data Quality Branch 4
Under Part D, FDA, OO has been
restructured as follows:
DCNK. ORGANIZATION. The Office
of FDA Commissioned Corps (OFCC) is
headed by the Director of FDA
Commissioned Corps.
VerDate Sep<11>2014
17:17 Jan 25, 2023
Jkt 259001
II. Delegations of Authority
Pending further delegation, directives,
or orders by the Commissioner of Food
and Drugs, all delegations and
redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegations, provided
they are consistent with this
reorganization.
III. Electronic Access
This reorganization is reflected in
FDA’s Staff Manual Guide (SMG).
Persons interested in seeing the
complete SMG can find it on FDA’s
website at: https://www.fda.gov/
AboutFDA/ReportsManualsForms/
StaffManualGuides/default.htm
(Authority: 44 U.S.C. 3101.)
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023–01567 Filed 1–25–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions,
and Delegations of Authority
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA), Office of
Operations (OO), Office of Enterprise
Management Services (OEMS) has
modified its structure. This new
organizational structure was approved
by the Deputy Secretary of Health and
Human Services on September 26, 2022,
and effective on September 26, 2022.
FOR FURTHER INFORMATION CONTACT:
Tiffany Branch, Associate Director for
Management, Office of Enterprise
Management Services, Office of
Operations, Food and Drug
Administration, 3 White Flint North,
11601 Landsdown Street, North
Rockville, MD 20852, 240–402–3156.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Introduction
Part D, Chapter D–B, (Food and Drug
Administration), the Statement of
Organization, Functions and
Delegations of Authority for the
Department of Health and Human
Services (35 FR 3685, February 25,
1970, 60 FR 56606, November 9, 1995,
64 FR 36361, July 6, 1999, 72 FR 50112,
August 30, 2007, 74 FR 41713, August
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
18, 2009, 76 FR 45270, July 28, 2011,
and 84 FR 22854, May 20, 2019) is
amended to reflect reorganization of
OEMS.
This reorganization realigned the FDA
History Office function from the Office
of the Commissioner (OC), Office of
External Affairs (OEA) to OO, OEMS
and revised the OEA and OEMS
functional statements to this function
realignment.
The Food and Drug Administration,
Office of Operations, Office of
Enterprise Management Services has
been restructured as follows:
DCNA. ORGANIZATION. OEMS is
headed by the Director of Enterprise
Management Services and includes the
following organizational units:
Division of Compliance and Conflict
Prevention
Division of Human Capital
Division of Information Governance
FDA History Office
Division of Resources Management
Division of Vendor Management
II. Delegations of Authority
Pending further delegation, directives,
or orders by the Commissioner of Food
and Drugs, all delegations and
redelegations of authority made to
officials and employees of affected
organizational components will
continue in them or their successors
pending further redelegations, provided
they are consistent with this
reorganization.
III. Electronic Access
This reorganization is reflected in
FDA’s Staff Manual Guide (SMG).
Persons interested in seeing the
complete SMG can find it on FDA’s
website at: https://www.fda.gov/
AboutFDA/ReportsManualsForms/
StaffManualGuides/default.htm.
(Authority: 44 U.S.C. 3101).
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023–01566 Filed 1–25–23; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2022–N–2174]
Oncologic Drugs Advisory Committee;
Notice of Meeting; Establishment of a
Public Docket; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
E:\FR\FM\26JAN1.SGM
26JAN1
]]>Agencies
[Federal Register Volume 88, Number 17 (Thursday, January 26, 2023)]
[Notices]
[Pages 5007-5008]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01567]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA), Office of Operations
(OO), Office of Talent Solutions (OTS) has modified its structure, and
the Office of FDA Commissioned Corps (OFCC) was established. These new
organizational structures were approved by the Deputy Secretary of
Health and Human Services on September, 26, 2022, and effective on
November, 2, 2022.
FOR FURTHER INFORMATION CONTACT: Tiffany Branch, Associate Director for
Management, Office of Enterprise Management Services, Office of
Operations, Food and Drug Administration, 3 White Flint North, 11601
Landsdown Street, North Bethesda, MD 20852, 240-402-3156.
SUPPLEMENTARY INFORMATION:
I. Introduction
Part D, Chapter D-B, (Food and Drug Administration), the Statement
of Organization, Functions and Delegations of Authority for the
Department of Health and Human Services (35 FR 3685, February 25, 1970,
60 FR 56606, November 9, 1995, 64 FR 36361, July 6, 1999, 72 FR 50112,
August 30, 2007, 74 FR 41713, August 18, 2009, 76 FR 45270, July 28,
2011, and 84 FR 22854, May 20, 2019) is amended to reflect the
reorganization of the OO, OTS and establishment of OO, OFCC.
This reorganization established the OO, OFCC. In the OTS immediate
office realigned the Commissioned Corps Staff (CCS) functions and
resources to OO, OFCC; established the Business Operations Staff;
retitled the Policy and Accountability Staff to Policy, Programs, and
Accountability Staff; and abolished the CCS.
In the Division of Talent Services, I (DTS I) retitled the division
to Division of Talent Solutions I (DTS I); retitled the CDER Branch 1
to Recruitment and Staffing Branch 1; retitled the CDER Branch 2 to
Recruitment and Staffing Branch 2; retitled the CDER Branch 3 to
Recruitment and Staffing Branch 3 (RSB3); established the Recruitment
and Staffing Branch 4; and established the Special Pay and Hiring
Branch.
In the Division of Talent Services II (DTS II) retitled the
division to Division of Talent Solutions II (DTS II); retitled the
CFSAN and CVM Branch to Recruitment and Staffing Branch 5; retitled OC
and NCTR Branch to Recruitment and Staffing Branch 6; retitled the OO
Branch to Recruitment and Staffing Branch 7; established the
Classification Branch 1; and established the Classification Branch 2.
In the Division of Talent Services III (DTS III) retitled the
division to Division of Talent Solutions III (DTS III); realigned the
CBER Branch functions and resources to DTS I/RSB3; realigned the CDRH
Branch functions and resources to DTS II and retitled as Recruitment
and Staffing Branch 8; realigned the CTP Branch functions and resources
to DTS II and retitled as Recruitment and Staffing Branch 9;
established the OTS/DTS III/Data Quality Branch 2; established the Data
[[Page 5008]]
Quality Branch 3; and established Data Quality Branch 4.
In the Division of Talent Services IV (DTS IV) realigned the ORA
Branch 1 functions to DTS III and retitled as the Recruitment and
Staffing Branch 10; realigned the ORA Branch 2 functions to DTS III and
retitled as the Recruitment and Staffing Branch 11; and abolished DTS
IV.
In the Division of Talent Sourcing and Staffing (DTSS) realigned
the Corporate Recruitment and Title 38 Branch functions and resources
to the OTS Immediate Office Executive Resources Staff and retitled as
the Scientific Programs and Executive Resources Staff; realigned the
Scientific Staffing and Outreach Branch functions and resources to the
OTS Immediate Office Scientific Talent Recruitment Staff and retitled
as the Science, Technology, Engineering, and Mathematics Outreach
Staff; realigned the Customer Care and Data Quality Branch functions
and resources to DTS III and retitled as the Data Quality Branch 1; and
abolished DTSS.
Under Part D, FDA, OO, OTS has been restructured as follows:
DCNJ. ORGANIZATION. The Office of Talent Solutions is headed by the
FDA Chief Talent Officer and includes the following organizational
units:
Business Operations Staff
Policy, Programs, and Accountability Staff
Scientific Programs and Executive Resources Staff
Science, Technology, Engineering, and Mathematics Outreach Staff
Division of Talent Solutions I
Recruitment and Staffing Branch 1
Recruitment and Staffing Branch 2
Recruitment and Staffing Branch 3
Recruitment and Staffing Branch 4
Special Hiring and Pay Branch
Division of Talent Solutions II
Recruitment and Staffing Branch 5
Recruitment and Staffing Branch 6
Recruitment and Staffing Branch 7
Recruitment and Staffing Branch 8
Recruitment and Staffing Branch 9
Classification Branch 1
Classification Branch 2
Division of Talent Solutions III
Recruitment and Staffing Branch 10
Recruitment and Staffing Branch 11
Delegated Examining Branch
Data Quality Branch 1
Data Quality Branch 2
Data Quality Branch 3
Data Quality Branch 4
Under Part D, FDA, OO has been restructured as follows:
DCNK. ORGANIZATION. The Office of FDA Commissioned Corps (OFCC) is
headed by the Director of FDA Commissioned Corps.
II. Delegations of Authority
Pending further delegation, directives, or orders by the
Commissioner of Food and Drugs, all delegations and redelegations of
authority made to officials and employees of affected organizational
components will continue in them or their successors pending further
redelegations, provided they are consistent with this reorganization.
III. Electronic Access
This reorganization is reflected in FDA's Staff Manual Guide (SMG).
Persons interested in seeing the complete SMG can find it on FDA's
website at: https://www.fda.gov/AboutFDA/ReportsManualsForms/StaffManualGuides/default.htm
(Authority: 44 U.S.C. 3101.)
Xavier Becerra,
Secretary of Health and Human Services.
[FR Doc. 2023-01567 Filed 1-25-23; 8:45 am]
BILLING CODE 4164-01-P
